A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies. (Q44061908)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37392552)
(Q92127474)
(P304) 2157-2166
(P407) (Q1860)
(P433) 7
(P478) 8
(P577) Monday, July 1, 2002
(P921) (Q323936)
(P1433) (Q332253)
(P1476) "A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies" (language: en)
(P2093) Eric K Rowinsky
Lisa A Hammond
Geoffrey R Weiss
Gary M Clark
Judy Moczygemba
Les Choi
Ron Linnartz
Nicholas C Barbet
Ivo T Sklenar
Renaud Capdeville
Gregory Gan
Carl W Porter
Daniel D Von Hoff
S Gail Eckhardt
other details
description scientific article

External Links